300 results on '"Argyle D"'
Search Results
2. Implantable biosensors and their contribution to the future of precision medicine
3. Transcriptomic analysis by RNA sequencing characterises malignant progression of canine insulinoma from normal tissue to metastatic disease
4. Switching on prodrugs using radiotherapy
5. Dual targeting of EGFR and ERBB2 pathways produces a synergistic effect on cancer cell proliferation and migration in vitro
6. Cover Image, Volume 15, Issue 3
7. The European canine lymphoma network: a joining initiative to generate consensus guidelines for the diagnosis and therapy in canine lymphoma and research partnership
8. Tumour-associated macrophages are associated with vascular endothelial growth factor expression in canine mammary tumours
9. Clinical research: developing an appropriate career structure
10. Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotype
11. Flow cytometric techniques for detection of candidate cancer stem cell subpopulations in canine tumour models
12. European consensus document on mast cell tumours in dogs and cats
13. Receptor tyrosine kinase inhibitors: molecularly targeted drugs for veterinary cancer therapy
14. Development of a questionnaire assessing health-related quality-of-life in dogs and cats with cancer
15. Expression of epidermal growth factor receptor (EGFR) and Ki67 in feline oral squamous cell carcinomas (FOSCC)
16. Identification of cancer stem cells in canine glioma and resistance to therapeutic modalities
17. Contributors
18. Tumor Biology and Metastasis
19. FELINE MYELOMA RELATED DISORDERS: CYTOLOGICAL ANALYSIS OF 13 CASES.: 8
20. Telomerase reverse transcriptase (TERT) expression and proliferation in canine brain tumours
21. Disease- and cell-type-specific transcriptional targeting of vectors for osteoarthritis gene therapy: further development of a clinical canine model
22. Cloning, sequencing, and characterization of dog interleukin-18
23. A novel gene therapy approach for canine osteoarthritis
24. Abstract P3-12-24: Tumor-secreted predictive biomarkers of response to radiotherapy in breast cancer
25. Antibiotic prophylaxis in veterinary cancer chemotherapy: A review and recommendations
26. Notch pathway inhibition targets chemoresistant insulinoma cancer stem cells
27. The European canine lymphoma network: a joining initiative to generate consensus guidelines for the diagnosis and therapy in canine lymphoma and research partnership
28. Canine and feline lymphoma: challenges and opportunities for creating a paradigm shift
29. Dual targeting of EGFR and ERBB2 pathways produces a synergistic effect on cancer cell proliferation and migration in vitro
30. EP-1895: Towards adaptive radiotherapy: a new registration-segmentation framework for focal prostate cancer
31. Exploring new biomarkers in the tumour microenvironment of canine inflammatory mammary tumours
32. The European canine lymphoma network: a joining initiative to generate consensus guidelines for the diagnosis and therapy in canine lymphoma and research partnership
33. European consensus document on mast cell tumours in dogs and cats
34. Differential sub-cellular immuno-localization of NOTCH-1 activated intracellular domain (NICD) in feline mammary tumours
35. Targeted knockdown of canine KIT (stem cell factor receptor) using small interfering RNA
36. Characterisation and cardiac directed differentiation of canine adult stem cells
37. Targeted knockdown of canine KIT (stem cell factor receptor) using RNA interference
38. Exploring new biomarkers in the tumour microenvironment of canine inflammatory mammary tumours.
39. DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies (vol 72, pg 7310, 1998)
40. DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies
41. Tumour‐associated macrophages are associated with vascular endothelial growth factor expression in canine mammary tumours
42. Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotype
43. Flow cytometric techniques for detection of candidate cancer stem cell subpopulations in canine tumour models
44. Development of a questionnaire assessing health-related quality-of-life in dogs and cats with cancer
45. Expression of epidermal growth factor receptor (EGFR) and Ki67 in feline oral squamous cell carcinomas (FOSCC)
46. Effect of recombinant feline interferon‐ω alone and in combination with chemotherapeutic agents on putative tumour‐initiating cells and daughter cells derived from canine and feline mammary tumours
47. Histopathologic, Immunohistochemical, and Cytologic Analysis of Feline Myeloma-Related Disorders: Further Evidence for Primary Extramedullary Development in the Cat
48. Evaluation of the gene for inducible nitric oxide synthase as a radiosensitizer under hypoxic and oxic conditions
49. Is cancer a stem cell disease? Theory, evidence and implications
50. Inhibition of telomerase in canine cancer cells following telomestatin treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.